Rachel Lenington - Net Worth and Insider Trading
Rachel Lenington Net Worth
The estimated net worth of Rachel Lenington is at least $11,238 dollars as of 2024-12-27. Rachel Lenington is the COO and CDO of Athira Pharma Inc and owns about 20,870 shares of Athira Pharma Inc (ATHA) stock worth over $11,238. Details can be seen in Rachel Lenington's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rachel Lenington has not made any transactions after 2024-09-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rachel Lenington
Rachel Lenington Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rachel Lenington owns 1 companies in total, including Athira Pharma Inc (ATHA) .
Click here to see the complete history of Rachel Lenington’s form 4 insider trades.
Insider Ownership Summary of Rachel Lenington
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATHA | Athira Pharma Inc | 2024-09-05 | Chief Technology Officer |
Rachel Lenington Latest Holdings Summary
Rachel Lenington currently owns a total of 1 stock. Rachel Lenington owns 20,870 shares of Athira Pharma Inc (ATHA) as of September 5, 2024, with a value of $11,238.
Latest Holdings of Rachel Lenington
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATHA | Athira Pharma Inc | 2024-09-05 | 20,870 | 0.54 | 11,238 |
Holding Weightings of Rachel Lenington
Rachel Lenington Form 4 Trading Tracker
According to the SEC Form 4 filings, Rachel Lenington has made a total of 4 transactions in Athira Pharma Inc (ATHA) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Athira Pharma Inc is the sale of 2,525 shares on September 5, 2024, which brought Rachel Lenington around $1,439.
Insider Trading History of Rachel Lenington
- 1
Rachel Lenington Trading Performance
Rachel Lenington Ownership Network
Rachel Lenington Owned Company Details
What does Athira Pharma Inc do?
Who are the key executives at Athira Pharma Inc?
Rachel Lenington is the Chief Technology Officer of Athira Pharma Inc. Other key executives at Athira Pharma Inc include See Below Andrew Gengos , Chief Operating Officer Mark James Litton , and Vice President of Discovery Kevin Church .
Athira Pharma Inc (ATHA) Insider Trades Summary
Over the past 18 months, Rachel Lenington made 3 insider transaction in Athira Pharma Inc (ATHA) with a net sale of 7,349. Other recent insider transactions involving Athira Pharma Inc (ATHA) include a net sale of 14,672 shares made by Mark James Litton , a net sale of 7,349 shares made by Mark Worthington , and a net sale of 4,937 shares made by Kevin Church .
In summary, during the past 3 months, insiders sold 0 shares of Athira Pharma Inc (ATHA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,787 shares of Athira Pharma Inc (ATHA) were sold and 648,086 shares were bought by its insiders, resulting in a net purchase of 611,299 shares.
Athira Pharma Inc (ATHA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Athira Pharma Inc Insider Transactions
Rachel Lenington Mailing Address
Above is the net worth, insider trading, and ownership report for Rachel Lenington. You might contact Rachel Lenington via mailing address: C/o Athira Pharma, Inc., 18706 North Creek Parkway, Suite 104, Bothell Wa 98011.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
